CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Speciality Medicines Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Speciality Medicines Ltd
Phone: +91 2246045344p:+91 2246045344 MUMBAI, 400093  India Ticker: 544738544738
Business Summary
Speciality Medicines Limited is an India-based pharmaceutical company. The Company is engaged in marketing and distribution of finished formulations of specialty pharmaceuticals. It offers a diverse portfolio of specialty pharmaceuticals, focusing on therapeutic areas such as oncology, immunology, neurology, and rare diseases. It deals in finished formulations of specialty pharmaceuticals, including capsules, cream, eye drops, gel, infusion, inhalation, inhaler, injection, nasal spray, ointment, ophthalmic, oral solution, oral suspension, sachet, suspension and tablet. Its product portfolio consists of more than 900 products, which comprises of wide range of therapeutic drugs such as ACE inhibitors, Analgesic, Antiulcer, Anti angiogenic, Anti-acne, and Anti fibrinolytic, among others. Under the sale of specialty pharmaceutical finished formulation in the domestic market, it sources existing Indian medicine brands from manufacturers and their authorized distributors.
(Source: Company's Website)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
3/31/20253/31/2025-----

Industries
SIC Code Description
5122 Drugs, drug proprietaries, and druggists' sundries

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Managing Director, Executive Chairman of the Board Parthkumar B.Goyani 34 6/1/2024 2/5/2021
Chief Financial Officer Rahul A.Shinde 25 6/26/2024 6/26/2024
Compliance Officer, Company Secretary Rashi K.Singh Daang 27 6/26/2024 6/26/2024
8 additional Officers and Directors records available in full report.

General Information
Stock Exchange: BOM


Copyright © 2026 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Sunday, March 29, 2026